Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
C1orf21-DT (C1orf21 divergent transcript) is a non-coding RNA gene located near the C1orf21 protein-coding gene on chromosome 1[3][5]. There is currently no experimental evidence for a distinct biological function, molecular pathway, therapeutic relevance, or disease association for C1orf21-DT. Most available scientific data describes C1orf21 (Proliferation-Inducing Protein 13) as an intracellular protein involved in cell proliferation and cancer, but does not mention the divergent transcript as a molecular target[2][3]. Thus, C1orf21-DT is not considered a validated therapeutic target and may be miscategorized if referenced as a receptor or similar protein class. The C1orf21-DT entry is likely incorrect or incomplete as a drug target or molecular receptor, since public sources only mention its existence as a non-coding RNA, with no validated functions or therapeutic relevance attributed to it. If you have queries about C1orf21 (the protein-coding gene), details including its function in cell proliferation and cancer are available, but for C1orf21-DT, authoritative molecular or clinical data is currently lacking[2][3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on C1orf21 divergent transcript (C1orf21-DT).